Eyenovia, Inc (EYEN)

Etorro trading 970x250
Eyenovia, Inc (EYEN) Logo

About Eyenovia, Inc

Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company, engages in developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, branded the Optejet. It focuses on achieving clinical microdosing of next-generation formulations of ophthalmic pharmaceutical agents using its ocular delivery system, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. The company, through its proprietary delivery technology, is developing smart ophthalmic therapies while targeting new indications for which there are currently no drug therapies approved by the U.S. Food and Drug Administration. Eyenovia, Inc. focuses on advancing its MicroLine program for the improvement in near vision in patients with presbyopia in Phase III development. Its other product candidates include MicroProst, which is in Phase III clinical trials for the treatment of chronic angle closure glaucoma, open angle glaucoma, and ocular hypertension; MicroStat, which has completed Phase III clinical trials for the treatment of mydriasis; MicroTears for the treatment of red eye and itch relief lubrication; and MicroPine for the treatment of progressive myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York. Address: 295 Madison Avenue, New York, NY, United States, 10017

Eyenovia, Inc News and around…

Latest news about Eyenovia, Inc (EYEN) common stock and company :

12 Health Care Stocks Moving In Tuesday's After-Market Session
14 Dec, 2021 FinancialContent

Gainers Star Equity Hldgs (NASDAQ:STRR) shares increased by 12.15% to $2.86 during Tuesday's after-market session. Trading volume for ...

Eyenovia (NASDAQ:EYEN) investors are sitting on a loss of 12% if they invested a year ago
10 Dec, 2021 Yahoo! Finance

The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...

Notable Eyenovia Insider Makes $360K Buy
17 Nov, 2021 Yahoo! Finance

Stuart M Grant, Insider at Eyenovia (NASDAQ:EYEN), made a large insider buy on November 16, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Grant purchased 100,000 shares of Eyenovia at at prices ranging from $3.52 to $3.67. The total transaction amounted to $360,750. Following the transaction, Grant now owns 4,623,989 shares of Eyenovia, worth $16,830,857. Eyenovia shares are trading up 2.82% at $3.64 at the t

Eyenovia, Inc. (EYEN) Reports Q3 Loss, Misses Revenue Estimates
10 Nov, 2021 Yahoo! Finance

Eyenovia, Inc. (EYEN) delivered earnings and revenue surprises of 11.54% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Eyenovia Reports Third Quarter 2021 Financial Results
10 Nov, 2021 Yahoo! Finance

On track with VISION-2 phase 3 presbyopia trial and expedited resubmission of MydCombi™ New Drug Application as a drug/device combination in early 2022 Current cash resources anticipated to be sufficient to cover MydCombi NDA resubmission, completion of Phase 3 MicroLine program, and completion of manufacturing facility Company to host conference call and webcast tomorrow, November 11, at 5:00pm ET NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophtha

Eyenovia to Participate in Myopia Panel Discussion at the Eyecelerator@AAO 2021 Meeting
08 Nov, 2021 Yahoo! Finance

Discussion to Include Future Potential Treatment Options, Including MicroPine (atropine ophthalmic spray), for reduction of myopia progression in pediatricsNEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology, today announced that Dr. Sean Ianchulev, Chief Executive Officer and Chief Medical Officer of Eyenovia, will pa

CORRECTING AND REPLACING: Eyenovia to Report Third Quarter 2021 Results on Wednesday, November 10
05 Nov, 2021 Yahoo! Finance

Eyenovia will release third quarter 2021 results on Wednesday, November 10, after the close. The prior version of this press release incorrectly stated that third quarter 2021 results would be released on Thursday, November 11, after the close. Company to host an investor conference call and webcast on Thursday, November 11 at 5:00pm ET NEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose arr

Eyenovia to Report Third Quarter 2021 Results on Thursday, November 11
04 Nov, 2021 Yahoo! Finance

Company to host an investor conference call and webcast at 5:00pm ET on that dayNEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, announced that the Company will release financial results for the third quarter ended September 30, 2021 on Thursday, November 11, 2021, after the market close. Following the release, Eyenovia management will host a conference ca

Eyenovia Announces First Patient Enrolled in Phase 3 VISION-2 Trial of MicroLine for Presbyopia
04 Nov, 2021 Yahoo! Finance

Vision-2 follows successful Vision-1 trial with expected top-line results in Q2 2022 Presbyopia represents a multi-billion-dollar market opportunity in the U.S. alone NEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that the first patient has been enrolled in the Company’s second Phase 3 clinical trial of MicroLine, its proprietary pilocarp

4 Penny Stocks Insiders Are Buying
04 Nov, 2021 FinancialContent

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Eyenovia, Inc. - EYEN
04 Nov, 2021 Yahoo! Finance

Pomerantz LLP is investigating claims on behalf of investors of Eyenovia, Inc. ("Eyenovia" or the "Company") (NASDAQ: EYEN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
02 Nov, 2021 FinancialContent

The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for ...

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
31 Oct, 2021 FinancialContent

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly ...

3 Penny Stocks Insiders Are Buying
28 Oct, 2021 FinancialContent

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...

Wednesday 10/27 Insider Buying Report: EYEN, INTC
27 Oct, 2021 FinancialContent

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Eyenovia, Inc. (EYEN) Investigation
26 Oct, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eyenovia, Inc. ("Eyenovia" or the "Company") (NASDAQ:EYEN).

56 Biggest Movers From Yesterday
26 Oct, 2021 FinancialContent

Gainers Bakkt Holdings, Inc. (NYSE: BKKT) shares jumped 234.4% to close at $30.60 on Monday after the company and Mastercard ...

Mid-Afternoon Market Update: Nasdaq Jumps 150 Points; Bakkt Holdings Shares Spike Higher
25 Oct, 2021 FinancialContent

Toward the end of trading Monday, the Dow traded up 0.26% to 35,771.26 while the NASDAQ rose 1.01% to 15,241.89. The S&P also rose, ...

12 Health Care Stocks Moving In Monday's Intraday Session
25 Oct, 2021 FinancialContent

Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current ...

Mid-Day Market Update: Crude Oil Rises Over 1%; ERYTECH Pharma Shares Plummet
25 Oct, 2021 FinancialContent

Midway through trading Monday, the Dow traded up 0.14% to 35,726.52 while the NASDAQ rose 0.52% to 15,168.16. The S&P also rose, ...

35 Stocks Moving In Monday's Mid-Day Session
25 Oct, 2021 FinancialContent

Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) shares jumped 122% to $1.8895 after the company announced its incubated company ...

Mid-Morning Market Update: Markets Edge Higher; Kimberly Clark Cuts FY21 Forecast
25 Oct, 2021 FinancialContent

Following the market opening Monday, the Dow traded up 0.07% to 35,700.45 while the NASDAQ rose 0.31% to 15,136.85. The S&P also ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
25 Oct, 2021 FinancialContent

Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 28.64% to $2.47 during Monday's pre-market session. The ...

Eyenovia Announces Reclassification of MydCombi(tm) as Drug-Device Combination Product by FDA
25 Oct, 2021 Yahoo! Finance

Genus Medical Technologies, LLC v. FDA legal case leads to agency-wide review and reclassification of eye cups, eye droppers, and ophthalmic dispensers Company received Complete Response Letter with additional requests and is preparing necessary documents for expedited resubmission NEW YORK, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that MydCo

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
24 Oct, 2021 FinancialContent

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
14 Oct, 2021 FinancialContent

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 34.63% to $12.71 during Thursday's pre-market session. ...

Is Eyenovia (NASDAQ:EYEN) Weighed On By Its Debt Load?
05 Oct, 2021 Yahoo! Finance

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

2 Healthcare Stocks With Big Catalysts in October
03 Oct, 2021 Yahoo! Finance

Healthcare stocks have a reputation of keeping investors on their toes. The possibility of surging price action, or conversely, earth shattering drops is very real, but these movements can come and go in the blink of an eye. As a result, these stocks need constant monitoring ahead of key catalysts, as they can affect the price dramatically. Additionally, the price movement is usually dependent on one of the following: either a regulatory approval or trial data. Once either is announced to the pu

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
01 Oct, 2021 FinancialContent

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug ...

Eyenovia (EYEN) Sees Hammer Chart Pattern: Time to Buy?
30 Sep, 2021 Yahoo! Finance

Eyenovia (EYEN) has been struggling lately, but the selling pressure may be coming to an end soon.

Eyenovia, Inc (EYEN) is a NASDAQ Common Stock listed in , ,

970x250